Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$90,310,136
-$5,069,624 QoQ
Shares Held
535,838
-26.0% QoQ
Ownership
0.527%
of shares outstanding
% of Portfolio
2.50%
of 13F equity value
Holder Rank
#36
of 768 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $319,058,775 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,646,201 | $123,074,808 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
535,838 | $90,310,136 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
13,932,000 | $58,653,720 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
336,000 | $15,882,720 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,958,702 | $15,512,919 | |
| 6 | EOLS |
Evolus, Inc.
|
1,436,000 | $9,965,840 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
8,705,589 | $5,658,632 |
All Filings in NBIX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $90,310,136 | 535,838 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $95,379,760 | 724,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $116,334,639 | 820,240 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $97,847,948 | 697,022 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $84,969,456 | 676,024 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $110,621,014 | 1,000,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $121,758,000 | 892,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,898,718 | 181,381 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $134,708,442 | 978,488 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $141,194,082 | 1,023,739 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $138,084,480 | 1,048,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $136,841,062 | 1,216,365 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $155,595,000 | 1,650,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $161,142,240 | 1,592,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $107,496,000 | 900,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $140,622,040 | 1,324,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,063,520 | 1,324,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $60,937,500 | 650,000 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||